Immune system activation via local inflammatory response

"Immune system activation via local inflammatory response" is **not a specific molecule or receptor**, but rather describes a complex physiological process involving the coordinated action of many cell types and molecular mediators. The local inflammatory response is triggered by tissue injury or infection and involves the release of chemical mediators such as histamine, prostaglandins, bradykinin, and various cytokines. These mediators cause vasodilation, increased vascular permeability, recruitment of immune cells like neutrophils and macrophages through chemotaxis, phagocytosis of pathogens/debris by these cells, and ultimately tissue repair[1][5][7]. Key molecular players in this process include pattern-recognition receptors (PRRs) like Toll-like receptors on innate immune cells; transcription factors such as NF‑κB; pro-inflammatory cytokines including TNF‑α and interleukins; chemokines; adhesion molecules; inflammasome complexes; among others[2][3][4]. While drugs can modulate this process—most notably NSAIDs targeting COX enzymes—the term itself does not refer to a discrete druggable target but rather an orchestrated biological event. **Conclusion:** This entry is *not* a canonical therapeutic target but instead refers to an entire biological pathway/process. For structured data purposes it should be flagged as incorrect for use as a single molecule/receptor target.

Other names

Local immune activationInflammatory responseLocal inflammation

NSAIDs inhibit cyclooxygenase enzymes (COX), reducing prostaglandin synthesis and thus dampening inflammatory signaling[5]